Quantum BioPharma Launches $7 Million Whistleblower Program Targeting Stock Manipulation
Quantum BioPharma has implemented a public whistleblower policy offering up to $7 million for verifiable evidence of stock manipulation, demonstrating the company's commitment to market integrity amid ongoing legal proceedings.
